- Home
- DCGO vs XTNT Comparison
DCGO vs XTNT Comparison
Compare DCGO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCGO | XTNT |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 61.7M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | DCGO | XTNT |
|---|---|---|
| Price | $0.37 | $0.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $2.38 | $1.00 |
| AVG Volume (30 Days) | 718.4K | ★ 2.9M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $322,196,000.00 | $53,337,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.77 | $9.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.35 | $0.27 |
| 52 Week High | $1.65 | $0.95 |
Technical Indicators
Market Signals| Indicator | DCGO | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 41.11 |
| Support Level | $0.35 | $0.27 |
| Resistance Level | $0.69 | $0.47 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 26.39 | 4.54 |
Price Performance
Historical ComparisonAbout DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.